Inactivation of p53 prevents senescence and allows Kmt5b-deficient MuSCs to pass the cell-cycle checkpoint, leading to malignant transformation and rhabdomyosarcoma formation. This evidence concerns the gene KMT5B and rhabdomyosarcoma.